Gene Expression May Lead To Improved Treatment Of Pediatric Septic Shock
Consistent with Cincinnati Children's increased emphasis on personalized and predictive medicine where diagnosis and treatment coincide with a person's genetic predispositio the study involves the largest gene expression analysis to date of blood samples from children with septic shock. It found new evidence linking adverse clinical outcomes with the decreased expression of genes that encode proteins involved in zinc regulation. This unexpected finding suggests these proteins and zinc regulation could provide a target for therapeutic intervention to inhibit septic shock's progression to multiple organ failure.
"Zinc was not even on our radar screen for this disease process," said Dr. Hector Wong, M.D., professor of Pediatrics and director of Critical Care Medicine at Cincinnati Children's. "This study demonstrates the potential power of genomic medicine for discovery and the generation of novel hypotheses. We are ultimately interested in determining whether or not there are biologically significant gene expression profiles that distinguish survivors from non-survivors. The rationale is to discover novel biomarkers of poor outcome and novel therapeutic targets as means for developing more effective treatment strategies."
The study published in the July issue of Physiological Genomics and consortium were led by Dr. Wong. The paper describes how comparative gene expression analysis of blood samples from children identified 63 genes expressed differently in patients with septic shock. This includes two forms of metallothionein where higher levels of metallothionein and lower levels of zinc were associated with increased chance of death. A total of 57 children participated in the study, which used individual micro-array chips to analyze samples from 15 control patients without septic shock and 42 patients with septic shock, including nine fatal cases.
The consortium was composed of 10 medical centers: Cincinnati Children's; Mott Children's Hospital at the University of Michigan; Children's Hospital and Research Center Oakland, Oakland, Calif.; Children's Hospital of Philadelphia; Children's Mercy Hospital, Kansas City; Penn State Children's Hospital, Hershey, Penn; University of Virginia Medical Center, Charlottesville, Va.; Newark Beth Israel Medical Center, Newark, N.J.; The University of Alabama at Birmingham and DuPont Hospital for Children, Wilmington, Del.
Researchers at Cincinnati Children's continue to investigate the potential for analyzing zinc levels as way to understand the biology of septic shock and allow for more effective therapeutic intervention. This includes the possibility of using zinc supplementation as a form of treatment.
Cincinnati Children's, one of the top five children's hospitals in the nation according to Child magazine, is a 475-bed institution devoted to bringing the world the joy of healthier kids. Cincinnati Children's is dedicated to providing care that is timely, efficient, effective, family-centered, equitable and safe. For its efforts to transform the way health care is provided, Cincinnati Children's received the 2006 American Hospital Association-McKesson Quest for Quality Prize®. Cincinnati Children's ranks second nationally among all pediatric centers in research grants from the National Institutes of Health and is a teaching affiliate of the University of Cincinnati College of Medicine. The Cincinnati Children's vision is to be the leader in improving child health.
Cincinnati Children's Hospital Medical Center
3333 Burnet Ave.
Cincinnati, OH 45229-3039
United States
http://www.cincinnatichildrens.org
Gene expresie poate duce la îmbunãtãþirea tratamentului de pediatrie ºoc septic - Gene Expression May Lead To Improved Treatment Of Pediatric Septic Shock - articole medicale engleza - startsanatate